September 27 Product: Sanofi and Regenerons Dupixent Indication : Chronic obstructive pulmonary disease Sanofi and Regeneron won a seventh indication for their blockbuster drug Dupixent Friday, as it became the first biologic medicine in the U.S
GLP-1 receptor agonists are just the beginning
Nicu C, O'Sullivan JDB, Ramos R, Timperi L, Lai T, Farjo N
Results: The study design of RECOVER-S and findings from a predefined interim analysis (n = 100 patients with 180-day follow-up) will be presented, providing a detailed overview of baseline characteristics, rehabilitation pathways and stroke recovery of enrolled patients
Double-blind, randomised, placebo-controlled study to evaluate the efficacy and safety of a fixed combination containing two plant extracts (Crataegus oxyacantha and Eschscholtzia californica) and magnesium in mild-to-moderate anxiety disorders
Altered composition of gut microbiota in depression: a systematic review